Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
If the data continues to hold up, the bigger impact may be earlier intervention delaying disease progression, reducing insulin dependence in some Type 2 diabetes patients, and changing how obesity and metabolic disease are managed as a system
But as the kilos drop and other health parameters improve, many are realising the harder part: generics are still distant and the financial strain is beginning to take shape.The scale of what patients are spending is reflected in the numbers
Key secondary endpoints included the proportion of participants with at least 10%, 15%, 20%, and 25% weight loss, as well as changes in waist circumference from baseline to week 72
The first two models revealed significant differences, with the hybrid approach offering a desirable blend of insights
